Study finds enzyme that effectively breaks down molecules used by bacteria
Bacteria often form robust biofilms to protect themselves, making them resistant to antibiotics and cleaning agents. Recent research has led to the development of an enzyme capable of breaking down signaling molecules crucial for biofilm formation in bacteria. Originating from a discovery in 2016 by KAUST researchers, seven quorum-quenching genes were identified from bacteria sourced from Red Sea sediment. These genes encode enzymes that disrupt the communication between bacteria by breaking down quorum-sensing molecules, inhibiting biofilm formation.
An interdisciplinary team of scientists utilized 3D protein modeling to predict the structures of the enzymes encoded by the identified genes. Through their analysis, they engineered an enzyme named LrsL, derived from the Red Sea Labrenzia bacterium, with potent lactonase activity. LrsL specifically targets acyl-homoserine lactones (AHLs), a class of quorum-sensing molecules. Experimental evaluations demonstrated that LrsL significantly inhibited biofilm formation in the notorious pathogenic bacterium Pseudomonas aeruginosa. Notably, LrsL exhibited unparalleled catalytic activity compared to existing quorum-quenching enzymes, presenting a promising solution for biofilm-related challenges.
The unique structural features of LrsL, such as an exceptional binding pocket, contribute to its robust enzymatic activity against a wide range of AHL molecules. Despite losing functionality above 50 degrees Celsius, LrsL can restore its structure and function upon cooling, showcasing remarkable stability even after exposure to high temperatures. This characteristic positions LrsL as a valuable candidate for diverse applications in clinical and industrial settings. With conventional biofilm treatments posing environmental and resistance concerns, the exceptional efficacy and stability of LrsL offer a sustainable and potent alternative for combating biofilm formation.
The development of LrsL marks a significant advancement in the field of enzyme-based biofilm inhibition, presenting a promising solution to combat bacterial biofilms’ resilience. By disrupting the communication network within bacterial communities, enzymes like LrsL offer a targeted and effective approach to prevent biofilm formation. The exceptional catalytic activity and stability of LrsL highlight its potential for various applications, from clinical settings to industrial processes. Moving forward, further research and optimization of quorum-quenching enzymes hold great promise in addressing biofilm-related challenges in diverse sectors.
Key Takeaways:
– Enzyme LrsL disrupts bacterial communication by targeting quorum-sensing molecules, inhibiting biofilm formation effectively.
– LrsL exhibits exceptional catalytic activity and stability, making it a promising candidate for biofilm-related applications in clinical and industrial settings.
– Quorum-quenching enzymes like LrsL offer a sustainable and potent alternative to conventional biofilm treatments, addressing environmental and resistance concerns.
Tags: immunotherapy
Read more on aninews.in